Kevin T. Conroy's Trading History
| ABTAbbott Laboratories | Sep 25, 2026 | Director | Uninformative Sell | 5.46M | $8.63M | |
| ALGNAlign Tech | May 22, 2026 | Director | Uninformative Buy | 285.10K | $532.56K | |
| EXASExact Sciences | Mar 23, 2026 | ― | Uninformative Buy | ― | $0.00 | |
| ADPTAdaptive Biotechnologies | Mar 08, 2023 | Director | Uninformative Buy | ― | $611.87K | |
| EPZMEpizyme | Aug 16, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| SLGCSomaLogic | Sep 03, 2021 | ― | Uninformative Buy | ― | $52.50K | |
| ~ARYAARYA Sciences Acquisition | ― | ― | ― | ― |
You May Also Like
Kevin T. Conroy insider profile FAQ
What is the percentage of profitable transactions made by Kevin T. Conroy?
The percentage of profitable transactions made by Kevin T. Conroy is 33%.
What is the average return per transaction made by Kevin T. Conroy?
The average return per transaction made by Kevin T. Conroy is -53.80%.
What stocks does Kevin T. Conroy hold?
Kevin T. Conroy holds: ABT, ALGN, EXAS, EPZM, ~ARYA, ADPT, SLGC stocks.
What was Kevin T. Conroy’s latest transaction?
Kevin T. Conroy’s latest transaction was an Uninformative Sell of $5.46M.
What was Kevin T. Conroy's most profitable transaction?
Kevin T. Conroy’s most profitable transaction was an Informative Buy of EXAS stock on December 28, 2015. The return on the trade was 82.30%.
What is Kevin T. Conroy's role in Abbott Laboratories?
Kevin T. Conroy's role in Abbott Laboratories is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.